Jørgen Ingerslev Selected Research

NN1731

1/2009	Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue.
4/2007	Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jørgen Ingerslev Research Topics

Disease

11	Hemorrhage 11/2012 - 07/2003
11	Hemophilia A (Haemophilia) 11/2012 - 04/2002
6	Thrombosis (Thrombus) 05/2012 - 06/2002
4	Thrombocytopenia (Thrombopenia) 08/2011 - 06/2006
3	Hyperhomocysteinemia 06/2006 - 07/2003
2	Factor VII Deficiency (Hypoproconvertinemia) 04/2013 - 02/2011
2	Infections 10/2011 - 10/2008
2	Type 2 Diabetes Mellitus (MODY) 05/2007 - 11/2006
2	Necrosis 05/2004 - 07/2002
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2013
1	Heart Diseases (Heart Disease) 05/2012
1	Thromboembolism 10/2011
1	Body Weight (Weight, Body) 02/2011
1	Critical Illness (Critically Ill) 12/2010
1	Afibrinogenemia (Fibrinogen Deficiency) 10/2009
1	Intracranial Hypertension 06/2009
1	Wounds and Injuries (Trauma) 01/2008
1	Diabetes Mellitus 11/2006
1	Venous Thromboembolism 10/2006
1	Osteonecrosis (Kienbock's Disease) 05/2004
1	Spinal Cord Injuries (Spinal Cord Injury) 05/2004
1	Thrombophilia 05/2004
1	Ischemia 05/2004
1	Homocystinuria 06/2002

Drug/Important Bio-Agent (IBA)

7	recombinant FVIIa (rFVIIa)FDA Link 01/2013 - 07/2003
7	Factor VIIa (Activated Factor VII)IBA 02/2011 - 07/2003
6	Fibrinogen (Factor I)FDA Link 01/2013 - 06/2005
6	Blood Coagulation Factors (Coagulation Factor)IBA 05/2012 - 08/2005
3	Proteins (Proteins, Gene)FDA Link 05/2007 - 04/2002
3	Folic Acid (Vitamin M)FDA LinkGeneric 06/2006 - 07/2003
2	Factor VII (Proconvertin)IBA 04/2013 - 10/2011
2	sugar formulated recombinant FVIIIIBA 11/2012 - 01/2008
2	Factor VIII (Coagulation Factor VIII)IBA 05/2012 - 04/2002
2	Prothrombin (Factor II)IBA 10/2011 - 04/2009
2	AutoantibodiesIBA 06/2010 - 04/2009
2	NN1731IBA 01/2009 - 04/2007
2	Thromboplastin (Tissue Factor)IBA 01/2009 - 06/2008
2	AntibodiesIBA 04/2007 - 04/2002
2	SteroidsIBA 05/2004 - 07/2002
1	Inosine Triphosphate (ITP)IBA 01/2013
1	Factor X (Stuart Factor)IBA 10/2011
1	Neutralizing AntibodiesIBA 10/2011
1	Indicators and Reagents (Reagents)IBA 08/2011
1	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 08/2011
1	KaolinIBA 08/2011
1	Colloids (Colloid)IBA 12/2010
1	salicylhydroxamic acid (SHAM)IBA 06/2009
1	Thrombin FDA Link 01/2009
1	InnovinIBA 01/2009
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2008
1	BuffersIBA 04/2007
1	Hemostatics (Antihemorrhagics)IBA 03/2007
1	Insulin (Novolin)FDA Link 11/2006
1	AntithrombinsIBA 10/2006
1	RNA (Ribonucleic Acid)IBA 06/2006
1	Methylprednisolone FDA LinkGeneric 05/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2004
1	Warfarin (Coumadin)FDA LinkGeneric 07/2003
1	Vitamin K FDA Link 07/2003
1	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 06/2002
1	S-Adenosylmethionine (Ademetionine)IBA 06/2002
1	HomocysteineIBA 06/2002
1	human F8 protein FDA Link 04/2002

Therapy/Procedure

5	Therapeutics 02/2011 - 04/2002
2	Drug Therapy (Chemotherapy) 01/2009 - 10/2008
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2013
1	Aftercare (After-Treatment) 06/2006
1	Orthopedic Procedures 01/2006